PAREXEL INVITES PUBLIC TO LISTEN TO LIVE WEBCAST OF ITS INVESTOR DAY JUNE 2, 2004
BOSTON, MA, May 20, 2004 — PAREXEL International Corporation (Nasdaq: PRXL), one of the largest contract biopharmaceutical outsourcing organizations in the world, announced today that it will broadcast its Investor Day live over the Internet on Wednesday, June 2nd from 8:30 a.m. to 12:30 p.m. ET.
PAREXEL will be discussing its growth strategy and vision for its markets, as well as its broad range of knowledge-based services. The day will include presentations and comments by the executive management team, including the Presidents of each of the Company’s business units.
Those who wish to listen to the Investor Day presentations and view the accompanying slides should log on to the Company’s website at www.parexel.com, click on “Investor Relations”, and then “Webcasts” fifteen minutes prior to the event to register, download and install any necessary software. After the conference, the event’s presentations will be archived and available on the Company’s website for one year.
PAREXEL is one of the largest biopharmaceutical outsourcing organizations in the world, providing a broad range of knowledge-based contract research, medical marketing and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. With a commitment to providing solutions that expedite time-to-market and peak market penetration, PAREXEL has developed significant expertise in clinical trials management, data management, biostatistical analysis, medical marketing, clinical pharmacology, regulatory and medical consulting, industry training and publishing and other drug development consulting services. Its information technology subsidiary, Perceptive Informatics, Inc., develops and offers a portfolio of innovative technology-based products and services that facilitate clinical drug development and are designed to decrease time to peak sales. The technology portfolio includes web-based portal solutions and tracking tools, Interactive Voice Response Systems (IVRS), Clinical Trial Management Systems (CTMS), electronic diary and investigator database solutions. Perceptive also offers advanced medical diagnostics services to assess rapidly and objectively the safety and efficacy of new drugs, biologics, and medical devices in clinical trials. PAREXEL’s integrated services, therapeutic area depth and sophisticated information technology, along with its experience in global drug development and product launch services, represent key competitive strengths. Headquartered near Boston, MA, PAREXEL operates in 52 locations throughout 36 countries around the world, and has 5,015 employees.